Multicentre, double-blind, randomised, placebo-controlled study on the prophylactic use of naldemedine for opioid-induced nausea and vomiting in patients with cancer (POSEIDON study): a protocol paper.
Ishihara Y et al.
NCBI PubMed Central · Papers · License: Open Access